Zhejiang Orient Gene Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.005x

Zhejiang Orient Gene Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Orient Gene Biotech Co Ltd (688298) has a cash flow conversion efficiency ratio of -0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-30.52 Million ≈ $-4.47 Million USD) by net assets (CN¥6.49 Billion ≈ $950.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Orient Gene Biotech Co Ltd (2016–2024)

Cash flow conversion efficiency of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024. This chart illustrates how Zhejiang Orient Gene Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang Orient Gene Biotech Co Ltd share price for real-time trading data and today's change.

Zhejiang Orient Gene Biotech Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang Orient Gene Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Orient Gene Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Orient Gene Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see market value of Zhejiang Orient Gene Biotech Co Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
HCM II Acquisition Corp. Unit NASDAQ:HONDU	-0.002x
Zhongjin Irradiation Incorporated Company SHE:300962	0.043x
Hangzhou Huasu Technology Co. Ltd. A SHE:301157	N/A
TINC Comm VA BR:TINC	0.022x
Goldiam International Limited NSE:GOLDIAM	-0.026x
Sunny Loan Top Co Ltd SHG:600830	0.007x
Ambiq Micro, Inc. NYSE:AMBQ	-0.030x
Northrim BanCorp Inc NASDAQ:NRIM	0.115x

Annual Cash Flow Conversion Efficiency for Zhejiang Orient Gene Biotech Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Orient Gene Biotech Co Ltd from 2016 to 2024. Review 688298 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.79 Billion ≈ $993.80 Million	CN¥-348.33 Million ≈ $-50.97 Million	-0.051x	+75.83%
2023-12-31	CN¥7.55 Billion ≈ $1.10 Billion	CN¥-1.60 Billion ≈ $-234.43 Million	-0.212x	-158.95%
2022-12-31	CN¥8.32 Billion ≈ $1.22 Billion	CN¥3.00 Billion ≈ $438.40 Million	0.360x	-52.35%
2021-12-31	CN¥6.89 Billion ≈ $1.01 Billion	CN¥5.20 Billion ≈ $761.49 Million	0.755x	+3.44%
2020-12-31	CN¥2.45 Billion ≈ $358.72 Million	CN¥1.79 Billion ≈ $261.98 Million	0.730x	+242.35%
2019-12-31	CN¥254.13 Million ≈ $37.19 Million	CN¥54.21 Million ≈ $7.93 Million	0.213x	+0.12%
2018-12-31	CN¥208.03 Million ≈ $30.44 Million	CN¥44.33 Million ≈ $6.49 Million	0.213x	-12.27%
2017-12-31	CN¥138.12 Million ≈ $20.21 Million	CN¥33.54 Million ≈ $4.91 Million	0.243x	+103.04%
2016-12-31	CN¥98.72 Million ≈ $14.45 Million	CN¥11.81 Million ≈ $1.73 Million	0.120x	--

About Zhejiang Orient Gene Biotech Co Ltd

SHG:688298 China Medical Devices

Market Cap

$524.81 Million

CN¥3.59 Billion CNY

Market Cap Rank

#11686 Global

#3344 in China

Share Price

CN¥17.79

Change (1 day)

+2.89%

52-Week Range

CN¥17.08 - CN¥28.54

All Time High

CN¥221.47